固体瘤中的抗体-药物结合物;癌症治疗的新策略
Toshiaki Takakura1, Toshio Shimizu1, Nobuyuki Yamamoto1
1Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University Faculty of Medicine, 811-1 Kimiidera, Wakayama, Wakayama 641-8510, Japan.
Japanese journal of clinical oncology
|May 4, 2024
概括
抗体-药物合物 (ADC) 通过将单克隆抗体与细胞毒性有效载荷联系起来,提供向癌症治疗. 虽然已批准的ADC显示了生存益处,但需要进一步了解克服发展挑战并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体-药物合物 (ADCs) 代表了癌症治疗的重大进展.
- 抗癌剂利用单克隆抗体对癌细胞提供有针对性的细胞毒性有效载荷.
- 几种ADC已被批准用于血液和固体瘤,证明了生存益处.
研究的目的:
- 简要介绍抗体与药物结合物的结构和机制.
- 审查目前在固体瘤中批准的ADCs的临床数据.
- 突出ADC发展的挑战和未来方向.
主要方法:
- 对ADC结构和功能的现有文献的审查.
- 对固体瘤中已批准的ADC进行临床试验数据的分析.
- 针对性癌症治疗的作用机制的讨论.
主要成果:
- ADCs包括单克隆抗体,链接器和用于向癌细胞破坏的有效载荷.
- 经批准的ADC已经在各种癌症中显示出临床上有意义的生存益处.
- 在ADC开发的挑战需要进一步的研究,以提高疗效和患者的结果.
结论:
- 抗癌药物是一种有前途的治疗类,在癌症治疗中已证明有效.
- 对ADC机制和挑战的更深入的理解对于推进该领域至关重要.
- 持续的研究和开发对于优化ADC治疗以获得更好的患者结果至关重要.
更多相关视频
07:36Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
5.3K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K